AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,640,892 | -1.9% | 80,711 | +0.9% | 0.45% | -1.3% |
| Q2 2023 | $5,748,800 | -51.8% | 80,000 | -58.6% | 0.45% | -56.7% |
| Q1 2023 | $11,922,066 | -27.5% | 193,289 | -9.4% | 1.04% | -36.0% |
| Q4 2022 | $16,450,981 | +90.1% | 213,289 | +9.9% | 1.63% | +38.6% |
| Q3 2022 | $8,656,000 | -6.8% | 194,000 | -20.0% | 1.18% | -18.7% |
| Q2 2022 | $9,288,000 | -7.5% | 242,500 | 0.0% | 1.45% | +5.1% |
| Q1 2022 | $10,037,000 | +9.6% | 242,500 | 0.0% | 1.38% | -29.5% |
| Q4 2021 | $9,162,000 | +11.2% | 242,500 | -3.0% | 1.95% | +61.5% |
| Q3 2021 | $8,240,000 | -51.1% | 250,000 | 0.0% | 1.21% | -51.5% |
| Q2 2021 | $16,865,000 | +19.1% | 250,000 | 0.0% | 2.50% | -22.6% |
| Q1 2021 | $14,155,000 | -30.5% | 250,000 | 0.0% | 3.22% | -8.2% |
| Q4 2020 | $20,368,000 | +14.3% | 250,000 | 0.0% | 3.51% | +1.5% |
| Q3 2020 | $17,813,000 | -13.4% | 250,000 | 0.0% | 3.46% | -18.8% |
| Q2 2020 | $20,570,000 | – | 250,000 | – | 4.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |